Pharmacokinetics of Low Molecular Weight Heparin and Unfractionated Heparin in Pregnancy

被引:0
|
作者
Mary H. H. Ensom
Mary D. Stephenson
机构
[1] University of British Columbia,Faculty of Pharmaceutical Sciences and Department of Obstetrics and Gynaecology
[2] British Columbia’s Women’s Hospital & Health Centre and British Columbia’s Research Institute for Children’s & Women’s Health,Reproductive Medicine Program
[3] OB7,Department of Pharmacy
[4] BC Women’s Hospital & Health Centre,undefined
来源
The Journal of the Society for Gynecologic Investigation: JSGI | 2004年 / 11卷
关键词
Antiphospholipid antibody syndrome; dalteparin; unfractionated heparin; pharmacokinetics; pregnancy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:377 / 383
页数:6
相关论文
共 50 条
  • [1] Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy
    Ensom, MHH
    Stephenson, MD
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (06) : 377 - 383
  • [2] The use of unfractionated heparin and low molecular weight heparins in pregnancy
    Casele, Holly L.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2006, 49 (04) : 895 - 905
  • [3] Unfractionated and low molecular weight heparin
    Marcelo Lima
    Helena Nader
    BMC Proceedings, 8 (Suppl 4)
  • [4] Reconsidering the Switch from Low-Molecular-Weight Heparin to Unfractionated Heparin during Pregnancy
    Pacheco, L. D.
    Saade, G. R.
    Costantine, M. M.
    Vadhera, R.
    Hankins, G. D. V.
    AMERICAN JOURNAL OF PERINATOLOGY, 2014, 31 (08) : 655 - 658
  • [5] Pharmacokinetics of the low molecular weight heparin dalteparin in cats
    Mischke, Reinhard
    Schmitt, Judith
    Wolken, Sonja
    Boehm, Claudia
    Wolf, Petra
    Kietzmann, Manfred
    VETERINARY JOURNAL, 2012, 192 (03) : 299 - 303
  • [6] Comparison of Continuation of Low-Molecular-Weight Heparin versus Switching to Unfractionated Heparin in the Peripartum
    Enakpene, Christopher A.
    Pontarelli, Kristina N.
    Della Torre, Micaela
    AMERICAN JOURNAL OF PERINATOLOGY, 2020, 37 (03) : 304 - 312
  • [7] Effect of low-molecular-weight heparin (Tinzaparin) and unfractionated heparin on platelet aggregation
    Ravn, HB
    Bregengaard, C
    Vissinger, H
    Ostergaard, P
    Holst, J
    Nielsen, HK
    Kristensen, SD
    Husted, SE
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1996, 2 (03) : 209 - 212
  • [8] DELAYED CUTANEOUS REACTION TO UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN AND DANAPAROID
    SIVAKUMARAN, M
    GHOSH, K
    MUNKS, R
    GELSTHORPE, K
    TAN, L
    WOOD, JK
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) : 893 - 894
  • [9] Effects of a low molecular weight heparin, Bemiparin, and unfractionated heparin on hemostatic properties of endothelium
    Pérez-Ruiz, A
    Montes, R
    Carrasco, P
    Rocha, E
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2002, 8 (01) : 65 - 71
  • [10] Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy
    Casele, HL
    Laifer, SA
    Woelkers, DA
    Venkataramanan, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (05) : 1113 - 1117